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Abstract
Teaching and learning anatomy by using human cadaveric specimens has been a 
foundation of medical and biomedical teaching for hundreds of years. Therefore, the 
majority of institutions that teach topographical anatomy rely on body donation pro-
grammes to provide specimens for both undergraduate and postgraduate teaching 
of gross anatomy. The COVID- 19 pandemic has posed an unprecedented challenge 
to anatomy teaching because of the suspension of donor acceptance at most insti-
tutions. This was largely due to concerns about the potential transmissibility of the 
SARS- CoV- 2 virus and the absence of data about the ability of embalming solutions 
to neutralise the virus. Twenty embalming solutions commonly used in institutions 
in the United Kingdom and Ireland were tested for their ability to neutralise SARS- 
CoV- 2, using an established cytotoxicity assay. All embalming solutions tested neu-
tralised SARS- CoV- 2, with the majority of solutions being effective at high- working 
dilutions. These results suggest that successful embalming with the tested solutions 
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1  |  INTRODUC TION
The use of human cadaveric specimens for anatomy teaching re-
mains a cornerstone of medical and scientific education (Ghosh, 
2017). There are currently 47 medical schools in the United 
Kingdom and Ireland, and at least 2600 worldwide (Duvivier et al., 
2014), the vast majority of which rely upon body donation and em-
balming preservation techniques (Habicht & Kiessling, 2018). The 
ongoing COVID- 19 pandemic resulted in immediate, widespread 
cessation of the acceptance of donor bodies by medical schools 
and universities, largely because of the perceived risks to staff 
and students (Brassett et al., 2020). Moreover, the challenge of 
community- based testing as well as the poor specificity and sen-
sitivity of some tests meant that there could not be any guaran-
tee that accepted donors were virus- free (Morgan et al., 2021). 
Critically, there have been no data published about the efficacy of 
anatomical embalming solutions to neutralise SARS- CoV- 2. Such 
data are urgently required in order to inform decisions about the 
safe resumption of body donation programmes and cadaver- based 
anatomy education. Therefore, in the current study, the ability of 
20 different, bespoke and commercial anatomical embalming solu-
tions used in the United Kingdom and Ireland, to neutralise SARS- 
CoV- 2, was tested. All 20 solutions tested were effective, several 
of them at high dilutions, resulting in effective neutralisation of 
anti- SARS- CoV- 2 at concentrations well below those used to em-
balm a body.
2  |  MATERIAL AND METHODS
2.1  |  Cell cultures
Vero E6 (ATCC® CRL- 1586™) cells were obtained from the MRC- 
University of Glasgow Centre for Virus Research. Cells were main-
tained at 37°C and 5% CO2 in Dulbecco Modified Eagle Medium 
(DMEM) supplemented with 10% foetal calf serum (FCS) and 1% 
penicillin/streptomycin.
2.2  |  Viral cultures
SARS- CoV- 2 Strain England 2 was obtained from Public Health 
England and propagated in Vero E6 cells for 72 h at 37°C and 5% 
CO2 in DMEM supplemented with 2% FCS and 1% penicillin/strep-
tomycin. After 72 h, the resulting supernatants were recovered and 
stored at −70°C. Viruses from second and third cell passages were 
used in all experiments.
2.2.1  |  Determination of cytotoxicity levels for each 
embalming solution
Vero E6 cells of 3 × 104 in 10% FCS supplemented DMEM were 
added to each well of a 96- well plate and incubated for 24– 36 h at 
37°C and 5% CO2. On the day of the experiment, two- fold dilutions 
(1:2– 1:8) were carried out for each embalming solution using DMEM 
supplemented with 2% FCS. Each two- fold dilution was further di-
luted 10- fold (101– 107) in 2% FCS supplemented DMEM to obtain 
a final volume of 50 µl/dilution. Samples of the diluted embalming 
solution were added to individual wells of a 96- well plate containing 
Vero E6 cells (described above) and incubated for 1 h at 37°C and 
5% CO2. After 1 h, 100 µl of DMEM supplemented with 2% FCS was 
added to each well and the plate was incubated for 72 h at 37°C 
and 5% CO2. After 72 h, cells were fixed for 1 h with 10% neutral- 
buffered formalin and then stained with 1% crystal violet (CV) in 
20% ethanol. Safe dilutions were those at which the embalming so-
lution was not toxic to Vero E6 cells.
2.3  |  Viral microtitration
Vero E6 cells were cultured in 96- well plates as described for the 
cytotoxicity assay above. Each embalming solution was diluted two- 
fold (1:2– 1:128) in 2% FCS supplemented DMEM in a final volume 
of 50 µl. The viral inoculum was prepared in 2% FCS supplemented 
DMEM at a range of 4.5 × 108– 4.5 × 1010 PFU/ml. A 50 µl aliquot 
of viral inoculum (~2.3 × 109 PFU) was added to 50 µl diluted em-
balming solution and incubated for 1 h at 37°C and 5% CO2. After 
this incubation period, each diluted embalming solution w/virus was 
further diluted 10- fold (101– 1010) in 2% FCS supplemented DMEM. 
Depending on the cytotoxicity, 50 µl samples of each dilution from 
104 or 105 to 109 or 1010 were transferred into wells of 96- well plates 
containing the previously prepared 3 × 104 Vero E6 cells. Then, Vero 
cells plus embalming solution/virus were incubated for 1 h at 37°C 
and 5% CO2 (adsorption phase). After the adsorption phase, 100 µl 
of 1.2% Avicel® PH- 101 solution in 2% FCS DMEM were added to 
each well before the cells were incubated again for 72 h at 37°C 
and 5% CO2. After 72 h, the cells were fixed in 150 µl of 10% neu-
tral buffered formalin for 3 h before being stained with 1% CV in 
20% ethanol solution. After staining, plaques were quantified, and 
can neutralise the SARS- CoV- 2 virus, thereby facilitating the safe resumption of body 
donation programmes and cadaveric anatomy teaching.
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viral titres were determined as previously published (Baer & Kehn- 
Hall, 2014). Each embalming solution and its two- fold dilutions were 
tested in three independent experiments.
3  |  RESULTS AND DISCUSSION
In order to rule out a potential direct cytotoxic effect of the em-
balming solutions tested on the Vero E6 cell system, dilutions of the 
embalming solutions that were non- toxic to Vero E6 cells were de-
termined. The non- toxic dilutions for each embalming fluid tested 
(safe dilution) are listed in Table 1. This eliminated any potential cy-
totoxic effects of the embalming solutions on the Vero E6 cells and 
ensured that data obtained would be based solely upon the ability of 
an embalming solution to neutralise the virus.
Almost half of the embalming solutions tested (nine out of 20, 
45%) showed the ability to neutralise the virus (>3- log10 reduc-
tion) at all dilutions (1:2– 1:256, corresponding to solution con-
centrations of 50%– 0.39% of the original solution that is used to 
embalm a body). Moreover, five out of 20 (25%) embalming solu-
tions showed the ability to neutralise the virus at most dilutions 
(1:2– 1:128, corresponding to 50%– 0.78% of the original). Two 
solutions showed the ability to neutralise the virus at dilutions 1:2– 
1:64 (50%– 1.56% concentration of the original), while four solu-
tions showed less ability to neutralise the virus (three solutions 
1:2– 1:16, concentration 50%– 6.25%, and one 1:2– 1:4, concentra-
tion 50%– 25%; Figure 1; Figures S1 and S2; Table 1). Interestingly, 
while embalming solutions with the low ability to neutralise the 
virus tended to have lower concentrations of formaldehyde, there 
were exceptions. These included for example solution 19 with a 
relatively high formaldehyde content and relatively lower efficacy 
against SARS- CoV- 2, and solutions 4, 17 and 18 which do not con-
tain any formaldehyde but showed efficient inhibitory activity 
(particularly solution 4 that performed also at very high dilutions). 
This may primarily be due to alternative ingredients such as glutar-
aldehyde (for solution 4) or phenol (for solutions 17 and 18).
These findings clearly demonstrate that all 20 solutions tested 
to neutralise the SARS- CoV- 2 virus in vitro, 14 of them at very high 
dilutions (up to 256 or 128 times, i.e. 0.39% or 0.78% of the origi-
nal solution). These data should inform decision- making about the 
safety of embalming procedures for the resumption of body donor 
programmes. From a practical point of view, embalming involves 
perfusion of approximately 20– 25 L of embalming fluid into an adult 
body, resulting in a dilution of approximately 1:4, that is a four- fold 
dilution of the embalming solution. Therefore, in the context of opti-
mal perfusion of the body with embalming solution, it is reasonable 
to suggest that the fluid that penetrates the body would remain at 
a higher concentration than the concentrations shown to inactivate 
the SARS- CoV- 2 in the current study. Therefore, the embalming 
solutions tested in the current study are likely to neutralise SARS- 
CoV- 2 in donor tissues when delivered using standard embalming 
procedures.
While this study provides significant reassurance that ana-
tomical embalming solutions effectively neutralise SARS- CoV- 2, 
it should be noted that donor bodies still need to be handled by 
technical personnel upon their arrival and during the embalming 
process. While this activity tends to involve small numbers of ap-
propriately trained professionals, it is clear that suitable Personal 
Protective Equipment and safety measures, such as those normally 
employed for embalming to protect against agents such as HIV, 
hepatitis B and Ebola still need to be rigorously employed. Similarly, 
despite the high efficacy of the embalming solutions tested in neu-
tralising SARS- Cov- 2, we continue to urge caution in accepting bod-
ies and avoid cases of suspected or certified SARS- CoV- 2 infection. 
The current findings leave the question open of how to operate 
fresh- frozen body donor programmes safely (such as those com-
monly used for surgical research and training; Hayashi et al., 2016), 
where donor material is not embalmed, given that SARS- CoV- 2 re-
mains stable and viable for longer at low temperatures (Aboubakr 
et al., 2021; Chin et al., 2020).
Interestingly, the soft embalming solutions tested, that is 4, 11, 
15, 16, 17, 18, 20, also showed efficacy in neutralising the virus and 
these may represent a suitable alternative during the COVID era 
for anatomical units otherwise routinely using fresh frozen bodies. 
In particular, as noted above, some of them do not contain formal-
dehyde (4, 17 and 18) and their embalming potential relies on the 
inclusion of biocides (significant amounts of glutaraldehyde and phe-
nol) that enable embalming and the neutralisation of SARS- CoV- 2, 
without the tissue fixation associated with classical formalin- based 
solutions.
F I G U R E  1  Schematic representation of the summary of the 
antiviral performance of the 20 embalming solutions tested at 
different dilutions starting from a 1:2 up to a 1:256 dilution. 
Solutions 1– 9 (red) neutralised the SARS- CoV- 2 at all dilutions 
tested, solutions 10– 14 (blue) neutralised the SARS- CoV- 2 up 
to a dilution of 1:128, solutions 15 and 16 (green) neutralised 
the SARS- CoV- 2 up to a dilution of 1:64, solutions 17– 19 (cyan) 
neutralised the SARS- CoV- 2 up to a dilution of 1:16 and solution 
20 (indigo) neutralised the SARS- CoV- 2 up to a dilution of 1:4. For 
details on the content of each solution, see Table 1 and Table S1. 
For the detailed graphic representation of the performance of each 
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In summary, our finding that all 20 anatomical embalming solu-
tions tested effectively neutralise the SARS- CoV- 2, and a number 
of them at concentrations much lower than they are normally used, 
provides a robust scientific basis upon which to make informed deci-
sions about the safe resumption of body donor programmes and the 
subsequent deployment of embalmed donors for undergraduate and 
postgraduate teaching.
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